EXPRESSÃO DO GENE CITED1 EM CARCINOMA PAPILÍFERO DE TIREÓIDE: UM POTENCIAL MARCADOR DIAGNÓSTICO
DOI:
https://doi.org/10.18066/revistaunivap.v25i49.1956
Abstract
O câncer de tireoide é a neoplasia mais comum do sistema endócrino, apresentando incidência crescente nos últimos anos. O diagnóstico é realizado principalmente pela associação de dois métodos: a ultrassonografia e a punção aspirativa por agulha fina (PAAF); porém ambos apresentam uma elevada taxa de resultados indeterminados. Deste modo, é necessária a busca de métodos diagnósticos alternativos para a obtenção de resultados mais precisos e confiáveis. A biologia molecular é uma área que se destaca nesse segmento de pesquisa, buscando compreender a biologia tumoral por meio da avaliação das alterações de expressão gênica. A técnica de PCR quantitativa em tempo real (RT-qPCR) é um método rápido e eficiente de detecção e quantificação de expressão gênica, apresentando alta sensibilidade e especificidade, e sendo considerada como uma ferramenta útil no diagnóstico de vários tipos de câncer. Neste estudo, amostras de carcinomas foliculares de tireoide, carcinomas papilíferos de tireoide, bócio adenomatoso e amostras de tecido normal da glândula foram obtidas com o objetivo de detectar marcadores moleculares diagnósticos por meio da avaliação da expressão dos genes TERT, CITED1 e SLC5A5 pela técnica de RT-qPCR, detectados com expressão aumentada nestas lesões, respectivamente. A expressão diferencial significativa foi detectada somente para o gene CITED1 na comparação das amostras de carcinoma papilífero de tireoide com bócio e tecidos normais, com aumento de expressão deste gene nas amostras de carcinoma papilifero. Os resultados obtidos sugerem o gene CITED1 como um potencial marcador diagnóstico em carcinoma papilífero de tireoide.
Downloads
Download data is not yet available.
References
AHN, S. H.; PARK, S. Y.; CHOI, S. I. Comparison of Consecutive Results from Fine Needle Aspiration and Core Needle Biopsy in Thyroid Nodules. Endococrine Pathology, vol.28, p.332-338, 2017.
ASAAD, N. Y. et al. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role. Journal of the Egyptian National Cancer Institute, v. 18, n. 1, p. 8-16, 2006.
BAHN, R. S.; CASTRO, M. R. Approach to the patient with nontoxic multinodular goiter. The Journal of Clinical Endocrinology & Metabolism, Rochester, v. 96, p. 1202-1212, 2011.
CHA, Y. J.; KOO, J. S. Next‑generation sequencing in thyroid cancer. Journal of Translational Medicine, v. 14, p. 322, 2016.
CHMIELIK E. et al. Heterogeneity of Thyroid Cancer. Pathobiology, v. 85, p. 117-129, 2018.
COELI, C. M. et al. Incidência e mortalidade por câncer de tireoide no Brasil. Arquivos Brasileiros de Endocrinologia & Metabologia, v. 49, n. 4, p. 503-509, 2005.
DE LA VIEJA, A. et al. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiological Reviews, New York, v. 80, n. 3, p. 1083-1105, 2000.
FUZIO, P. et al. Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy? BMC Cancer (BioMed Central), v. 15, p. 1-10, 2015.
KIM, S-W. et al. Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips. Journal of Pathology and Translational Medicine, v. 50, p. 411-418, 2016.
KIRSCHNER, L. S. et al. Mouse models of thyroid cancer: A 2015 update. Molecular and Cellular Endocrinology, v. 421, p.18-27, 2016.
LEE, S. E. et al. Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAFV600E Mutation–Prevalent Population. Thyroid, v. 26, n. 7, p. 901-910, 2016.
LI, H. et al. CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27. Cell & bioscience, v. 8, n. 57, p. 1-9, 2018.
LIU, C. et al. TERT promoter mutation and its association with clinicopathological features and prognosis of papillary thyroid cancer: a meta-analysis. Scientific reports, v.6, 2016a.
LIU, R. et al. TERT promoter mutations in thyroid cancer. Endocrine-related cancer, v. 23, n. 3, p. 143-155, 2016b.
MARINA, M. et al. Size of thyroid carcinoma by histotype and variants: A population-based study in a mildly iodine-deficient area. Head Neck, v. 39, n. 10, p. 2095-2103, 2017.
MOGHADDAM, P. A. et al. Five Top Stories in Thyroid Pathology. Archives of Pathology & Laboratory Medicine, v.140, p.158-70, 2016.
NA, D. G. et al. Core Needle Biopsy of the Thyroid: 2016 Consensus Statement and Recommendations from Korean Society of Thyroid Radiology. Korean Journal of Radiology, v.18, p. 217-237, 2017.
NEUMANN, S. et al. Linkage of Familial Euthyroid Goiter to the Multinodular Goiter-1 Locus and Exclusion of the Candidate Genes Thyroglobulin, Thyroperoxidase, and Na+/I− Symporter 1. Journal of Clinical Endocrinology & Metabolism, v.84, p.3750-3756, 1999.
PAN, D. H. et al. The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases. OncoTargets and Therapy, v. 10, p. 3261-3276, 2017.
PFAFFL, M. W. A new mathematical model for relative quantification in real-time rt-pcr. Nucleic Acids Research, v. 29, n. 9, 2001.
PRASAD, M. L. et al. CITED1 protein expression suggests papillary thyroid carcinoma in high through put tissue microarray-based study. Thyroid, p.169-175, 2004.
RIA, R. et al. Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma. Oncotarget, v.7, p.29677-88, 2016.
RING, A. et al. Wnt/catenin signaling in adult stem cell physiology and disease. Stem Cell Reviews and Reports, v. 10, p. 512-25, 2014.
RÍOS, A. et al. Utility of elastography in thyroid nodules with indeterminate cytology. Endocrinología, Diabetes y Nutrición (English ed.), v. 64, n. 3, p. 180-182, 2017.
RODRIGUES, H. G. C.; PONTES, A. B. N.; ADAN, L. F. F. Use of molecular markers in samples obtained from preoperative aspiration of thyroid. Endocrine Journal, v. 59, p. 417-24, 2012.
UPADYAYA, A. et al. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer. Medicine, v.96, p.1-9, 2017.
XIA, E. et al. CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer. Oncology Letters, v. 16, p. 105-112, 2018.
WANG, N. et al. TERT promoter mutation as anearly genetic eventactivating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. Cancer, v. 120, p. 2965-79, 2014.
WANG, S. et al. Differential expression of the Na+/I-symporterprotein in thyroid cancer and adjacent normal and nodular goiter tissues. Oncology letters, v.1, p.368-372, 2013.
YIP, L. Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy. Journal of surgical oncology, v. 111, p. 43-50, 2015.
Downloads
Published
2019-12-17
How to Cite
Rodrigues, C. B. S., Silva, R. M., Pupin, B., & Canevari, R. de A. (2019). EXPRESSÃO DO GENE CITED1 EM CARCINOMA PAPILÍFERO DE TIREÓIDE: UM POTENCIAL MARCADOR DIAGNÓSTICO. Revista Univap, 25(49), 104–115. https://doi.org/10.18066/revistaunivap.v25i49.1956
Issue
Section
Ciências da Saúde
License
This work is licensed under a Creative Commons Attribution 4.0 International.
This license allows others to distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation.
http://creativecommons.org/licenses/by/4.0/legalcode
DOI:
https://doi.org/10.18066/revistaunivap.v25i49.1956Abstract
O câncer de tireoide é a neoplasia mais comum do sistema endócrino, apresentando incidência crescente nos últimos anos. O diagnóstico é realizado principalmente pela associação de dois métodos: a ultrassonografia e a punção aspirativa por agulha fina (PAAF); porém ambos apresentam uma elevada taxa de resultados indeterminados. Deste modo, é necessária a busca de métodos diagnósticos alternativos para a obtenção de resultados mais precisos e confiáveis. A biologia molecular é uma área que se destaca nesse segmento de pesquisa, buscando compreender a biologia tumoral por meio da avaliação das alterações de expressão gênica. A técnica de PCR quantitativa em tempo real (RT-qPCR) é um método rápido e eficiente de detecção e quantificação de expressão gênica, apresentando alta sensibilidade e especificidade, e sendo considerada como uma ferramenta útil no diagnóstico de vários tipos de câncer. Neste estudo, amostras de carcinomas foliculares de tireoide, carcinomas papilíferos de tireoide, bócio adenomatoso e amostras de tecido normal da glândula foram obtidas com o objetivo de detectar marcadores moleculares diagnósticos por meio da avaliação da expressão dos genes TERT, CITED1 e SLC5A5 pela técnica de RT-qPCR, detectados com expressão aumentada nestas lesões, respectivamente. A expressão diferencial significativa foi detectada somente para o gene CITED1 na comparação das amostras de carcinoma papilífero de tireoide com bócio e tecidos normais, com aumento de expressão deste gene nas amostras de carcinoma papilifero. Os resultados obtidos sugerem o gene CITED1 como um potencial marcador diagnóstico em carcinoma papilífero de tireoide.Downloads
References
AHN, S. H.; PARK, S. Y.; CHOI, S. I. Comparison of Consecutive Results from Fine Needle Aspiration and Core Needle Biopsy in Thyroid Nodules. Endococrine Pathology, vol.28, p.332-338, 2017.
ASAAD, N. Y. et al. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role. Journal of the Egyptian National Cancer Institute, v. 18, n. 1, p. 8-16, 2006.
BAHN, R. S.; CASTRO, M. R. Approach to the patient with nontoxic multinodular goiter. The Journal of Clinical Endocrinology & Metabolism, Rochester, v. 96, p. 1202-1212, 2011.
CHA, Y. J.; KOO, J. S. Next‑generation sequencing in thyroid cancer. Journal of Translational Medicine, v. 14, p. 322, 2016.
CHMIELIK E. et al. Heterogeneity of Thyroid Cancer. Pathobiology, v. 85, p. 117-129, 2018.
COELI, C. M. et al. Incidência e mortalidade por câncer de tireoide no Brasil. Arquivos Brasileiros de Endocrinologia & Metabologia, v. 49, n. 4, p. 503-509, 2005.
DE LA VIEJA, A. et al. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiological Reviews, New York, v. 80, n. 3, p. 1083-1105, 2000.
FUZIO, P. et al. Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy? BMC Cancer (BioMed Central), v. 15, p. 1-10, 2015.
KIM, S-W. et al. Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips. Journal of Pathology and Translational Medicine, v. 50, p. 411-418, 2016.
KIRSCHNER, L. S. et al. Mouse models of thyroid cancer: A 2015 update. Molecular and Cellular Endocrinology, v. 421, p.18-27, 2016.
LEE, S. E. et al. Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAFV600E Mutation–Prevalent Population. Thyroid, v. 26, n. 7, p. 901-910, 2016.
LI, H. et al. CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27. Cell & bioscience, v. 8, n. 57, p. 1-9, 2018.
LIU, C. et al. TERT promoter mutation and its association with clinicopathological features and prognosis of papillary thyroid cancer: a meta-analysis. Scientific reports, v.6, 2016a.
LIU, R. et al. TERT promoter mutations in thyroid cancer. Endocrine-related cancer, v. 23, n. 3, p. 143-155, 2016b.
MARINA, M. et al. Size of thyroid carcinoma by histotype and variants: A population-based study in a mildly iodine-deficient area. Head Neck, v. 39, n. 10, p. 2095-2103, 2017.
MOGHADDAM, P. A. et al. Five Top Stories in Thyroid Pathology. Archives of Pathology & Laboratory Medicine, v.140, p.158-70, 2016.
NA, D. G. et al. Core Needle Biopsy of the Thyroid: 2016 Consensus Statement and Recommendations from Korean Society of Thyroid Radiology. Korean Journal of Radiology, v.18, p. 217-237, 2017.
NEUMANN, S. et al. Linkage of Familial Euthyroid Goiter to the Multinodular Goiter-1 Locus and Exclusion of the Candidate Genes Thyroglobulin, Thyroperoxidase, and Na+/I− Symporter 1. Journal of Clinical Endocrinology & Metabolism, v.84, p.3750-3756, 1999.
PAN, D. H. et al. The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases. OncoTargets and Therapy, v. 10, p. 3261-3276, 2017.
PFAFFL, M. W. A new mathematical model for relative quantification in real-time rt-pcr. Nucleic Acids Research, v. 29, n. 9, 2001.
PRASAD, M. L. et al. CITED1 protein expression suggests papillary thyroid carcinoma in high through put tissue microarray-based study. Thyroid, p.169-175, 2004.
RIA, R. et al. Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma. Oncotarget, v.7, p.29677-88, 2016.
RING, A. et al. Wnt/catenin signaling in adult stem cell physiology and disease. Stem Cell Reviews and Reports, v. 10, p. 512-25, 2014.
RÍOS, A. et al. Utility of elastography in thyroid nodules with indeterminate cytology. Endocrinología, Diabetes y Nutrición (English ed.), v. 64, n. 3, p. 180-182, 2017.
RODRIGUES, H. G. C.; PONTES, A. B. N.; ADAN, L. F. F. Use of molecular markers in samples obtained from preoperative aspiration of thyroid. Endocrine Journal, v. 59, p. 417-24, 2012.
UPADYAYA, A. et al. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer. Medicine, v.96, p.1-9, 2017.
XIA, E. et al. CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer. Oncology Letters, v. 16, p. 105-112, 2018.
WANG, N. et al. TERT promoter mutation as anearly genetic eventactivating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. Cancer, v. 120, p. 2965-79, 2014.
WANG, S. et al. Differential expression of the Na+/I-symporterprotein in thyroid cancer and adjacent normal and nodular goiter tissues. Oncology letters, v.1, p.368-372, 2013.
YIP, L. Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy. Journal of surgical oncology, v. 111, p. 43-50, 2015.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International.
This license allows others to distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation.
http://creativecommons.org/licenses/by/4.0/legalcode